Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1979 Sep;55(647):587–592. doi: 10.1136/pgmj.55.647.587

Antifungal therapy, 1978.

G L Baum
PMCID: PMC2425647  PMID: 392475

Abstract

The past 40 years have brought great advances in the knowledge of morphology, immunology and epidemiology of fungal infections in man. Each general advance in the science of medicine has had its counterpart in man's improved facility to deal with these infections therapeutically. Although satisfactory control of fungal infections of man is still lacking, productive paths of investigation seem to have been found and the continued application of rigorous discipline to research efforts should provide even more efficient treatment in the future.

Full text

PDF
587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLANK H., ROTH F. J., Jr The treatment of dermatomycoses with orally administered griseofulvin. AMA Arch Derm. 1959 Mar;79(3):259–266. doi: 10.1001/archderm.1959.01560150001001. [DOI] [PubMed] [Google Scholar]
  2. GENTLES J. C. Experimental ringworm in guinea pigs: oral treatment with griseofulvin. Nature. 1958 Aug 16;182(4633):476–477. doi: 10.1038/182476a0. [DOI] [PubMed] [Google Scholar]
  3. GRUNBERG E., BERGER J., TITSWORTH E. Chemotherapeutic studies on a new antifungal agent, X-5079C, effective against systemic mycoses. Am Rev Respir Dis. 1961 Oct;84:504–506. doi: 10.1164/arrd.1961.84.4.504. [DOI] [PubMed] [Google Scholar]
  4. Godefroi E. F., Heeres J., Van Cutsem J., Janssen P. A. The preparation and antimycotic properties of derivatives of 1-phenethylimidazole. J Med Chem. 1969 Sep;12(5):784–791. doi: 10.1021/jm00305a014. [DOI] [PubMed] [Google Scholar]
  5. HAZEN E. L., BROWN R. Two antifungal agents produced by a soil actinomycete. Science. 1950 Oct 13;112(2911):423–423. [PubMed] [Google Scholar]
  6. JAMBOR W. P., STEINBERG B. A., SUYDAM L. O. Amphotericins A and B: two new antifungal antibiotics possessing high activity against deep-seated and superficial mycoses. Antibiot Annu. 1955;3:574–578. [PubMed] [Google Scholar]
  7. Kobbayashi G. S., Medoff G., Schlessinger D., Kwan C. N., Musser W. E. Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum. Science. 1972 Aug 25;177(4050):709–710. doi: 10.1126/science.177.4050.709. [DOI] [PubMed] [Google Scholar]
  8. LAMPEN J. O., MORGAN E. R., SLOCUM A. Effect of nystatin on the utilization of substrates by yeast and other fungi. J Bacteriol. 1957 Sep;74(3):297–302. doi: 10.1128/jb.74.3.297-302.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Levine H. B. R34000, a dioxolane imidazole in the therapy for experimental coccidioidomycosis. Comparison with miconazole and econazole. Chest. 1976 Dec;70(6):755–759. doi: 10.1378/chest.70.6.755. [DOI] [PubMed] [Google Scholar]
  10. MARINI F., ARNOW P., LAMPEN J. O. The effect of monovalent cations on the inhibition of yeast metabolism by nystatin. J Gen Microbiol. 1961 Jan;24:51–62. doi: 10.1099/00221287-24-1-51. [DOI] [PubMed] [Google Scholar]
  11. Oxford A. E., Raistrick H., Simonart P. Studies in the biochemistry of micro-organisms: Griseofulvin, C(17)H(17)O(6)Cl, a metabolic product of Penicillium griseo-fulvum Dierckx. Biochem J. 1939 Feb;33(2):240–248. doi: 10.1042/bj0330240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Plempel M., Bartmann K., Büchel K. H., Regel E. BAY b 5097, a new orally applicable antifungal substance with broad-spectrum activity. Antimicrob Agents Chemother (Bethesda) 1969;9:271–274. [PubMed] [Google Scholar]
  13. Plempel M., Bartmann K., Büchel K. H., Regel E. Experimentelle Befunde über ein neues, oral wirksames Antimykotikum mit breiten Wirkungsspektrum. Dtsch Med Wochenschr. 1969 Jun 27;94(26):1356–passim. doi: 10.1055/s-0028-1111223. [DOI] [PubMed] [Google Scholar]
  14. SCHOENBACH E. B., MILLER J. M., GINSBERG M., LONG P. H. Systemic blastomycosis treated with stilbamidine; a preliminary report. J Am Med Assoc. 1951 Aug 4;146(14):1317–1318. doi: 10.1001/jama.1951.63670140005011c. [DOI] [PubMed] [Google Scholar]
  15. SNAPPER I., McVAY L. V., Jr The treatment of North American blastomycosis with 2-hydroxystilbamidine. Am J Med. 1953 Nov;15(5):603–623. doi: 10.1016/0002-9343(53)90150-8. [DOI] [PubMed] [Google Scholar]
  16. Stevens D. A., Levine H. B., Deresinski S. C. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. doi: 10.1016/0002-9343(76)90428-9. [DOI] [PubMed] [Google Scholar]
  17. Symmers W. S. Amphotericin pharmacophobia. Br Med J. 1973 Nov 24;4(5890):460–463. doi: 10.1136/bmj.4.5890.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. WILLIAMS D. I., MARTEN R. H., SARKANY I. Oral treatment of ringworm with griseofulvin. Lancet. 1958 Dec 6;2(7058):1212–1213. doi: 10.1016/s0140-6736(58)92363-8. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES